5-Amino-1MQ
5-Amino-1MQ, an NNMT inhibitor sold as a research chemical: its unapproved FDA status, the mouse-only evidence and unknown human risks.
Not approved, research chemical · Evidence grade D · Reviewed
Not approved by the FDA for human use. Not for human consumption. This page describes 5-Amino-1MQ only to explain its regulatory status, what has been studied and its known risks. Drawline does not recommend obtaining or using it. Disclaimer
- Not approvedFat lossMouse data only; never tested in people
WADA does not name it, but its S0 class bans any pharmacological substance with no current government approval for human use, which would cover 5-Amino-1MQ.
Drug-tested athletes can look up any substance on Global DRO, run by national anti-doping agencies. Supplements can contain banned substances that are not on the label. Drawline does not suggest when to train or inject.
5-Amino-1MQ (5-amino-1-methylquinolinium, 5-amino-1-methylquinolinium iodide, 5A1MQ). NNMT inhibitor (small molecule).
DNot approved, research chemical. Evidence grade D: animal and lab data only.
What is 5-Amino-1MQ?
5-Amino-1MQ is a small lab-made molecule, not a peptide, that blocks the enzyme nicotinamide N-methyltransferase (NNMT). It is sold online as a research chemical in tablets and injectable vials and marketed for fat loss.
Is 5-Amino-1MQ FDA-approved?
FDA has never approved 5-Amino-1MQ for any use, and no company has published a human trial of it. In a warning letter dated January 20, 2026, FDA told the outsourcing facility GenoGenix LLC that drugs compounded with 5-Amino-1MQ are not eligible for the section 503B exemptions, because the substance is not on the 503B bulks list. It is not a controlled substance.
What does the evidence show for 5-Amino-1MQ?
All published efficacy data come from cells and mice. Researchers at the University of Texas Medical Branch reported less body weight and fat mass in obese mice on a high-fat diet (2018, and a 28-day study in 2024). No published human trial was found.
What are the known risks of 5-Amino-1MQ?
No human safety data exist, so side effects and the long-term effects of blocking NNMT in people are unknown. Research-chemical products are not made under drug manufacturing rules, so their identity, strength and purity are not verified, and injectable vials may not be sterile. Sport: WADA does not name it, but its S0 class bans any pharmacological substance with no current government approval for human use, which would cover 5-Amino-1MQ.
How is 5-Amino-1MQ measured?
A tablet, so there is nothing to draw or calculate. Products sold online as "research use only" have no assurance of identity, dose or sterility. The calculator can do the arithmetic for any vial, but it cannot tell you what is actually in one.
Sources: FDA warning letter: GenoGenix LLC (January 20, 2026); Neelakantan et al.: NNMT inhibitors reverse diet-induced obesity in mice (Biochemical Pharmacology); NNMT inhibition mitigates obesity-related metabolic dysfunction (Diabetes, Obesity and Metabolism, 2024); WADA Prohibited List. This profile does not recommend any dose or use.
For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.
Keep reading
Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.